Otolith Labs Announces Closing of $3.3 Million in Seed Financing; Receives “Breakthrough Device” Designation from FDA for Its Prescription Treatment for Vertigo
Investors include Mark Cuban; founders of three companies acquired by large strategics; and four leading ENTs.